Clinical Trial Update: MAD Study of IA-14069 [Phase 1]

View source ↗

Summary

Phase 1 multiple-ascending-dose study of IA-14069 by ILAb Co., Ltd. is currently recruiting. The trial will enroll healthy volunteers and patients with rheumato…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• IA-14069

Snippet

Sponsor: ILAb Co., Ltd. | Conditions: Healthy, Rheumatoid Arthritis | Phase 1 | Status: RECRUITING